Biochemical Improvement after Treatment by Bone Marrow Transplantation in I-Cell Disease

16Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The first case of successful bone marrow transplantation (BMT) in a patient with I-cell disease is reported. A 8-month-old girl with I-cell disease (N-acetylglucosaminylphosphotransferase deficiency) has had successful reconstitution with bone marrow from her HLA-MLC-matched brother who has heterozygous level of the transferase activity. The following biochemical and clinical improvements have occurred: the transferase in peripheral lymphocytes increased to donor's level, and lymphocytic α-neuraminidase, β-galactosidase and α-mannosidase increased to normal levels. Plasma acid hydrolase activities, which had been 10 to 60 times higher in the patient than normal control levels, have slowly but steadily decreased from one month after the graft. Such decreases were observed in the activities of α-mannosidase, N-acetyl-β-glucosaminidase, α-fucosidase, arylsulfatase A and acidic β-galactosidase. There was also a marked decrease of vacuolated peripheral lymphocyte after the BMT. Three-months after the engraftment, hepatomegaly gradually decreased in size, corneal clouding has not progressed, and tight skin seems to have improved. © 1986, Tohoku University Medical Press. All rights reserved.

Cite

CITATION STYLE

APA

Kurobane, I., Inoue, S., Gotoh, Y. I., Kato, S., Tamura, M., Narisawa, K., & Tada, K. (1986). Biochemical Improvement after Treatment by Bone Marrow Transplantation in I-Cell Disease. The Tohoku Journal of Experimental Medicine, 150(1), 63–68. https://doi.org/10.1620/tjem.150.63

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free